| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.07B | +11.5% |
| Cost of Revenue | $1.33B | +19.4% |
| Gross Profit | $4.73B | +9.5% |
| R&D Expense | $1.08B | +2.5% |
| SG&A Expense | $2.09B | +16.5% |
| Operating Income | $1.26B | -8.3% |
| Pre-tax Income | $1.27B | -17.8% |
| Income Tax | $216.9M | +42.6% |
| Net Income | $1.07B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.94B | -3.5% |
| Short-term Investments | $1.29B | +38.4% |
| Accounts Receivable | $659.6M | +8.3% |
| Inventory | $1.13B | +3.6% |
| Current Assets | $6.74B | +7.2% |
| Total Assets | $13.70B | +4.9% |
| Current Liabilities | $1.81B | +20.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.60B | +194.2% |
| Capital Expenditures | $260.2M | +3.1% |
| Investing Cash Flow | -$712.9M | -130.8% |
| Financing Cash Flow | -$956.8M | +2.7% |
| Free Cash Flow | $1.33B | +360.5% |
| -74.3% |
| EPS (Basic) | $1.84 | -73.6% |
| EPS (Diluted) | $1.83 | -73.7% |
| Long-term Debt |
| $598.3M |
| +0.1% |
| Total Liabilities | $3.36B | +12.3% |
| Stockholders' Equity | $10.34B | +3.4% |